Curebay raises Rs 100 crore in pre-series C led by IvyCap Ventures

Curebay raises Rs 100 crore funding

Curebay, the Bangalore‑based healthtech platform focused on underserved areas, disclosed on Monday that it has closed a Rs 100 crore pre‑Series C round. IvyCap Ventures acted as lead investor, while existing backers Elevar Equity, Bertelsmann India Investments and others also participated.

Who backed the round

The financing split into roughly Rs 69 crore of equity and about Rs 30 crore of debt. The debt tranche came from Trifecta Capital, Alteria Capital and VentureSoul Partners. Existing shareholders, including Elevar Equity and Bertelsmann India Investments, reinforced their stakes alongside IvyCap.

What the capital will fund

"We will use this capital to expand our footprint, strengthen our AI capabilities and enter new markets, starting with Andhra Pradesh," said Priyadarshi Mohapatra, co‑founder and CEO, in a statement to the Economic Times. The funds are earmarked for scaling the network of technology‑enabled clinics, upgrading the AI‑driven health‑screening platform, and deepening the command‑centre that supports 24/7 clinical decision‑making.

Curebay’s rural health footprint

Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain, Curebay now runs over 250 clinics across seven states. The model blends physical clinics with a community‑health‑worker network, a digital platform and AI‑powered diagnostics. More than 1,800 Swasthya Mitras, 530 trained clinical staff, 230 doctor partners and 210 partner hospitals and labs underpin the operation.

The startup reports having served more than 17 lakh patients and conducts over 400 health camps each month. Its six‑layer system—physical sites, community workers, digital tools, AI screening, a 24/7 command centre and the Curebay Kavach platform—aims to deliver affordable, quality care in remote locations.

Government partnership and broader impact

Curebay is a designated health partner for Samriddhi Kendra, a Government of India initiative that seeks to improve rural health outcomes. The collaboration highlights how private tech firms are aligning with national priorities to expand healthcare access.

Analysts view the raise as a vote of confidence in India’s healthtech sector, which has attracted increasing capital as the country pushes to meet its ambitious universal health‑care goals. With the new funding, Curebay is poised to deepen its role in that national agenda, leveraging AI and a scalable clinic model to bridge gaps in rural health delivery.

Looking ahead

The company’s next steps include rolling out its platform in Andhra Pradesh, enhancing AI algorithms for faster disease detection, and exploring additional partnerships with state health departments. As the round demonstrates, investors remain keen to back home‑grown solutions that combine technology, infrastructure and a clear social mission.